Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020

Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018–2020

Abstract Background A pillar of the United States’ Ending the HIV Epidemic (EHE) initiative is to rapidly provide antiretroviral therapy (ART) in order to achieve HIV viral suppression. However, insurance benefit design can impede ART access. The primary objective of this study is to understand how...

Full description

Bibliographic Details
Main Authors: Rohan Khazanchi, Samuel Powers, Amy Killelea, Andrew Strumpf, Tim Horn, Auntré Hamp, Kathleen A. McManus
Format: Article
Language:English
Published: Taylor & Francis Group 2023-04-01
Series:Journal of Pharmaceutical Policy and Practice
Subjects:
HIV
Access to care
Pharmacoequity
Drug pricing
Coverage
Coinsurance
Online Access:https://doi.org/10.1186/s40545-023-00559-8

Internet

https://doi.org/10.1186/s40545-023-00559-8

Similar Items